The Clinical Impact of Who Standardization of Psa Assays Klini^ki Uticaj Who Standardizacije Na Psa Testove
نویسندگان
چکیده
EAU Congress, Milan. 2008. 33. Stephan C, Kahrs A, Klotzek S, Reiche J, Müller C, LeinM, et al. Toward the metrological traceability in deter-mination of prostate-specific antigen: the new AccessHybritech assays calibrated against WHO standardscompared with the traditional Access Hybritech assays.CCLM 2008; in press. 34. Stephan C, Kahrs A, Klotzek S, Reiche J, Müller C, LeinM, et al. Comparison of the »gold« standard AccessPSA (Hybritech) assay with the new Beckman CoulterWHO-standardized calibrated Access PSA assaysabstract . EAU Congress, Milan. 2008. 35. Stenman UH, Paus E, Allard WJ, Andersson I, AndresC, Barnett TR, et al. Summary report of the TD-3 work-shop: characterization of 83 antibodies against pro-state-specific antigen. Tumour Biol 1999; 20 Suppl 1:1–12. Received: April 10, 2008 Accepted: May 10, 2008
منابع مشابه
Standardization of prostate-specific antigen (PSA) assays: can interchangeability of PSA measurements be improved?
The landscape of prostate cancer has changed since the appearance of the first prostate-specific antigen (PSA) assay. PSA testing has gained rapid recognition since M. Kuriyama et al. (1 ) of Roswell Park first reported clinical studies using an enzyme immunoassay with anti-PSA rabbit antibody. Mikolajczyk and coworkers (2, 3) reported the presence of several free PSA isoforms and the potential...
متن کاملWHO first international standards for prostate-specific antigen: the beginning of the end for assay discrepancies?
Despite the success of prostate-specific antigen (PSA) as a tumor marker for the early detection and monitoring of disease in prostate cancer, both clinical and analytical limitations of PSA remain (1 ). Since the introduction of assays for total PSA in the mid-1980s, assay results have been found to differ among manufacturers (2, 3). Much has been learned in the last two decades about the biol...
متن کاملPSA Screening in Prostate Cancer
Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...
متن کاملImpact of liver function on serum level of prostate specific antigen (PSA) in cirrhotic patients, before and after receiving liver transplant.
Introduction: Prostate cancer is the most prevalent malignancies among males. Prostate specific antigen (PSA) is used for screening of this malignancy. Serum levels of PSA is influenced by liver function. This study evaluate variations of serum levels of PSA amongst cirrhotic patients, before and after receiving liver transplantation. Material and methods: all cirrhotic males older than 45 y...
متن کاملAssessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: a simulation study based on the population of the United Kingdom.
BACKGROUND Prostate-specific antigen (PSA) is the most widely used serum biomarker to differentiate between malignant and benign prostate disease. Assays that measure PSA can be biased and/or nonequimolar and hence report significantly different PSA values for samples with the same nominal amount. This report investigates the effects of biased and nonequimolar assays on the decision to recommen...
متن کامل